AstraZeneca s Covid-19 Antibody Treatment Failed To Prevent Symptoms In Exposed Individuals

Get the Full StoryThe monoclonal antibody treatment reduced the risk of developing symptomatic Covid-19 by a statistically insignificant 33 among unvaccinated adults.

Share:

More in Business...

Big retail chains are generating a lot of pollution despite pushback

The FCC votes to reinstate net neutrality rules, reversing Trump

Italy, Spain, and Greece are piloting tourist taxes and locals are conflicted

Ring home security customers will get refunds over security-lapse claims

Congo questions Apple s knowledge of blood minerals in its supply chain